Chemotherapy-Related Thrombocytosis: Does It Increase the Risk of Thromboembolism?

Abstract

Although gemcitabine-based therapy has been associated with an increased incidence of thrombocytosis, it does not increase the risk of thromboembolism in cancer patients. Leukocytosis and comorbid illnesses do increase the risk of thromboembolism.